Literature DB >> 17593069

Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.

K A Nyrop1, O S Palsson, R L Levy, M Von Korff, A D Feld, M J Turner, W E Whitehead.   

Abstract

AIM: To provide estimates of actual costs to deliver health care to patients with functional bowel disorders, and to assess the cost impact of symptom severity, recency of onset, and satisfaction with treatment.
METHODS: We enrolled 558 irritable bowel (IBS), 203 constipation, 243 diarrhoea and 348 abdominal pain patients from primary care and gastroenterology clinics at a health maintenance organization within weeks of a visit. Costs were extracted from administrative claims. Symptom severity, satisfaction with treatment and out-of-pocket expenses were assessed by questionnaires.
RESULTS: Average age was 52 years, 27% were males, and 59% participated. Eighty percent were seen in primary care clinics. Mean annual direct health care costs were $5049 for IBS, $6140 for diarrhoea, $7522 for constipation and $7646 for abdominal pain. Annual out-of-pocket expenses averaged $406 for treatment of IBS symptoms, $294 for diarrhoea, $390 for constipation and $304 for abdominal pain. Lower gastrointestinal costs comprised 9% of total costs for IBS, 9% for diarrhoea, 6.5% for constipation and 9% for abdominal pain. In-patient care accounted for 17.5% of total costs (15.2% IBS).
CONCLUSION: Costs were affected by disease severity (increased), recent exacerbation of bowel symptoms (increased), and whether the patient was consulting for the first time (decreased).

Entities:  

Mesh:

Year:  2007        PMID: 17593069     DOI: 10.1111/j.1365-2036.2007.03370.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  70 in total

Review 1.  Recent advances in the management of difficult constipation.

Authors:  Brian E Lacy; John Levenick; Michael Crowell
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Clinical features of constipation in general practice in Italy.

Authors:  Carmelo Cottone; Cesare Tosetti; Giuseppe Disclafani; Enzo Ubaldi; Rosanna Cogliandro; Vincenzo Stanghellini
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

3.  Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.

Authors:  Reuben K Wong; Olafur S Palsson; Marsha J Turner; Rona L Levy; Andrew D Feld; Michael von Korff; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2010-05-25       Impact factor: 10.864

Review 4.  When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain.

Authors:  Madhusudan Grover
Journal:  Curr Gastroenterol Rep       Date:  2012-08

5.  Chronic constipation: new diagnostic and treatment approaches.

Authors:  Brian E Lacy; John M Levenick; Michael Crowell
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

6.  Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome.

Authors:  Brian E Lacy; John M Levenick; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

7.  Conditioned pain modulation in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert J Shulman; Kevin C Cain; Wimon Deechakawan; Lynne T Smith; Philippe Richebé; Margaret Eugenio; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2014-01-24       Impact factor: 2.522

8.  Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.

Authors:  M M Walker; N J Talley; M Prabhakar; C J Pennaneac'h; P Aro; J Ronkainen; T Storskrubb; W S Harmsen; A R Zinsmeister; L Agreus
Journal:  Aliment Pharmacol Ther       Date:  2009-01-17       Impact factor: 8.171

9.  Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome.

Authors:  Tisha N Lunsford; Lucinda A Harris
Journal:  Int J Womens Health       Date:  2010-10-27

10.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.